Dexmedetomidine (Precedex) in the Progressive Care Unit

Facilitator(s): Rachael M Georges, RN; Geralyn M Esworthy, MSN,BSN,CCRN, RN-BC

Contact Hours 1.25
CERP A 1.25
Philadelphia Conference
Date Tuesday 5/23/2023
Time 4:15 PM - 5:30 PM ET
Room 120B
Available On Demand
From Monday 6/12/2023
To Tuesday 10/31/2023

Session Summary

This session presents an advanced overview of dexmedetomidine (Precedex) and its use in the Progressive Care and Stepdown units. Dexmedetomidine is a relatively selective alpha2-adrenergic agonist indicated for use outside of the ICU for improved tolerance of noninvasive respiratory support, alcohol/opiate withdrawal- adjunctive therapy and ICU transfer on low-dose therapy when ICU admission criteria are otherwise no longer met.


  • Identify the purpose and rationale for utilizing dexmedetomidine (Precedex) in the Progressive Care and Stepdown units.
  • Describe administration protocols, associated clinical endpoints, and documentation.
  • Discuss how to manage patients undergoing treatment including addressing potential adverse effects.
Topics Medication Management
Population Adult
Role Staff

Call for Abstracts: Have a great idea for a session or a poster?
Click here to apply.

Continuing Education Disclosure Statement

Successful Completion

Learners must attend/view/read the entire activity and complete the associated evaluation to be awarded the contact hours or CERP. No partial credit will be awarded.


This activity has been reviewed by the Nurse Planner. It has been determined that the material presented here shows no bias. No conflicts of interest have been identified for any individual with the ability to influence the content of this activity. Accreditation refers to recognition of continuing education only and does not imply AACN or ANCC approval or endorsement of any commercial products discussed or displayed in conjunction with this educational activity.


The American Association of Critical-Care Nurses (AACN) is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's (ANCC's) Commission on Accreditation, ANCC Provider Number 0012. AACN has been approved as a provider of continuing education in nursing by the California State Board of Nursing (CBRN), California Provider number CEP 1036. This activity is approved for 1.25 contact hours.

AACN programming meets the standards for most states that require mandatory continuing education contact hours for license and/or certification renewal. AACN recommends consulting with your state board of nursing or credentialing organization before submitting CE to fulfill continuing education requirements.

Refund Policy

Continuing Education Activities are nonrefundable.